What is the recommended evaluation and management for a patient with a 7q11.23 duplication?

7q11.23 Duplication Syndrome: Evaluation and Management

All patients with confirmed 7q11.23 duplication require comprehensive cardiovascular surveillance with echocardiography to monitor for aortic dilation (particularly ascending aorta), neuroimaging with brain MRI to assess for structural abnormalities, and intensive speech-language therapy given the high prevalence of motor speech disorders.

Initial Diagnostic Workup

When 7q11.23 duplication is identified (typically via chromosomal microarray as recommended by current genetic testing guidelines 1), proceed with systematic evaluation:

Cardiovascular Assessment (Critical Priority)

• Obtain baseline echocardiography immediately - aortic dilation occurs in 46.2% of patients, most commonly affecting the ascending aorta, with less frequent involvement of aortic root and sinotubular junction 2, 3
• This represents the opposite vascular phenotype of Williams-Beuren syndrome (which causes supravalvar aortic stenosis)
• Establish serial cardiovascular surveillance protocol given progressive nature 3
• Screen for patent ductus arteriosus (present in 15% of cases) 2

Neurological Evaluation

• Order brain MRI - structural abnormalities found in 81.6% including:
  • Decreased cerebral white matter volume
  • Cerebellar vermis hypoplasia
  • Ventriculomegaly 2, 4
• Neurological examination abnormalities occur in 88.7% of children 2
• Assess for seizure history (present in 19%) and establish monitoring plan 2

Developmental and Speech Assessment

• Refer immediately for intensive speech-language therapy - 82.6% have Speech Sound Disorder, with high prevalence of Childhood Apraxia of Speech, dysarthria, and/or phonological disorders 2, 5
• Evaluate for Developmental Coordination Disorder (74.2% affected) 2
• Screen for hypotonia (58.5% prevalence) 2

Physical Examination Focus

Document characteristic craniofacial features:

• Brachycephaly, broad forehead, straight eyebrows
• Broad nasal tip, low insertion of columella, short philtrum, thin upper lip
• Minor ear anomalies and facial asymmetry 2
• Measure head circumference - macrocephaly in 30% of newborns and 50% of older children/adults 2

Additional Medical Surveillance

Endocrine

• Screen for growth hormone deficiency (9.4% prevalence) 2

Gastrointestinal

• Address chronic constipation proactively (66% affected) 2

Renal

• Obtain renal ultrasound to evaluate for structural anomalies (18% prevalence) 2

Behavioral and Psychiatric Management

Establish monitoring and treatment plans for:

• Anxiety disorders (most common behavioral issue)
• ADHD
• Oppositional disorders 2
• Social anxiety, particularly in unfamiliar situations 5

Genetic Counseling Considerations

Critical caveat: 27% of probands have an affected parent 2, and inheritance patterns show 42.9-50% of duplications are inherited 6. This is substantially higher than typical de novo rates for genomic disorders. Parental testing is essential for:

• Recurrence risk counseling
• Identifying mildly affected or asymptomatic parents
• Family planning guidance 7, 6

Seven of 26 examined de novo duplications showed inversions, with all seven having a parent with common inversion polymorphism of the Williams-Beuren region 2 - this increases recurrence risk.

Clinical Pitfalls

• Do not assume normal cardiovascular exam excludes aortopathy - echocardiography is mandatory as aortic dilation may be asymptomatic 3
• Do not delay speech therapy - early intensive intervention is critical for maximizing long-term outcomes 5
• Do not overlook parental evaluation - phenotypic variability means parents may be minimally affected or asymptomatic carriers 7, 8